中文 | English
Return
Total: 6122 , 1/613
Show Home Prev Next End page: GO
Author:( Shu WANG)

1.Anti-thyroid drugs—first choice for Graves' disease

Shu WANG

Chinese Journal of Practical Internal Medicine 2003;0(01):-

2.Analysis of Cause-related Marketing Strategy in Pharmaceutical Industry

Shuling WANG ; Shu WANG

China Pharmacy 2005;0(16):-

4.Immunoregulation of radix tanshinone on isolated-lung preservation

Yongjian WANG ; Ping SHU

Chinese Journal of Primary Medicine and Pharmacy 2008;15(5):705-706

5.Clinical Evaluation of the Level of Serum CA125 for Hepatic Functional Lesion in Patients with Cirrhosis

Donghai ZHANG ; Shu WANG

Journal of Medical Research 2006;0(07):-

6.Endoscopic diagnosis and treatment of Barrett's esophagus

Shu LI ; Bangmao WANG

Chinese Journal of Practical Internal Medicine 2001;0(09):-

7.Discussion on Customer Value Management in Pharmaceutical Enterprises

Shu WANG ; Yuwen CHEN

China Pharmacy 1991;0(04):-

8.CIK cells and their application in the tumor treatment

Xin SHU ; Zhiyu WANG

Journal of International Oncology 2015;42(2):130-133

9.Effect of Hongjingtian injection adjuvant therapy on blood glucose, blood lipid and clinical efficacy in patients with acute cerebral infarction

Shu CHEN ; Zongshe WANG

Chinese Journal of Biochemical Pharmaceutics 2015;(11):158-160

10.Analysis of Clinical and Pathological Characteristics and Prognosis in 21 Children with Primary Focal Segmental Glomerulosclerosis

shu, TENG ; mo, WANG

Journal of Applied Clinical Pediatrics 1992;0(05):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 6122 , 1/613 Show Home Prev Next End page: GO